Insider Transactions in Q2 2023 at Ani Pharmaceuticals Inc (ANIP)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2023
|
Chad Gassert SVP - CORP. DEV. & STRATEGY |
SELL
Open market or private sale
|
Indirect |
20,000
-5.09%
|
$1,020,000
$51.32 P/Share
|
|
Jun 22
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Direct |
13,500
-64.57%
|
$688,500
$51.38 P/Share
|
|
Jun 21
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Direct |
11,843
-36.16%
|
$603,993
$51.95 P/Share
|
|
Jun 20
2023
|
Muthusamy Shanmugam HEAD OF R&D, COO-NOVITIUM OPS |
SELL
Open market or private sale
|
Direct |
14,657
-30.92%
|
$747,507
$51.93 P/Share
|
|
May 23
2023
|
Antonio R Pera Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+15.78%
|
-
|
|
May 23
2023
|
Thomas Haughey Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+12.72%
|
-
|
|
May 23
2023
|
David Nash Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+15.11%
|
-
|
|
May 23
2023
|
Jeanne Thoma Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+15.94%
|
-
|
|
May 23
2023
|
Patrick D Walsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+8.9%
|
-
|
|
May 23
2023
|
Renee P Tannenbaum Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,865
+25.35%
|
-
|
|
Apr 10
2023
|
James G. Marken SVP OPS & PROD DEV |
SELL
Payment of exercise price or tax liability
|
Direct |
2,289
-1.71%
|
$86,982
$38.5 P/Share
|
|
Apr 10
2023
|
Stephen P. Carey SVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,534
-2.55%
|
$172,292
$38.5 P/Share
|